促销时间表 BioCardia, Inc.
先进的时间表
简单图表
关于公司 BioCardia, Inc.
BioCardia, Inc., a clinical-stage regenerative medicine company, engages in development of cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP, an autologous mononuclear cell therapy system for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary disease. 更多详情IPO date | 2008-03-14 |
---|---|
ISIN | US09060U5074 |
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Сайт | https://www.biocardia.com |
Цена ао | 2.55 |
每日价格变化: | +4.48% (2.68) |
---|---|
每周价格变化: | +5.26% (2.66) |
每月价格变化: | +33.33% (2.1) |
3个月内价格变化: | +13.82% (2.46) |
六个月内的价格变化: | -10.26% (3.12) |
每年价格变化: | +587.96% (0.407) |
3年内价格变化: | +30.23% (2.15) |
5年内价格变化: | -24.22% (3.695) |
年初以来价格变化: | +28.44% (2.18) |
|
低估
|
效率
|
|||||||||||||||||||||||||||||||||||||
股息
|
责任
|
成长冲动
|
机构 | 体积 | 分享, % |
---|---|---|
CM Management, LLC | 700000 | 14.44 |
Vanguard Group Inc | 650763 | 13.42 |
Geode Capital Management, LLC | 159648 | 3.29 |
Renaissance Technologies, LLC | 88300 | 1.82 |
Family Management Corporation | 77500 | 1.6 |
Susquehanna International Group, LLP | 65426 | 1.35 |
Blackrock Inc. | 42767 | 0.88 |
Virtu Financial LLC | 41348 | 0.85 |
Citadel Advisors Llc | 33629 | 0.69 |
Brown Advisory Inc. | 33085 | 0.68 |
导师 | 职称 | 支付 | 出生年份 |
---|---|---|---|
Dr. Peter A. Altman Ph.D. | CEO, President & Director | 515.51k | 1967 (58 年) |
Mr. David McClung | Chief Financial Officer | 370.86k | 1963 (62 年) |
Mr. Edward M. Gillis | Senior Vice President of Devices | 263.1k | 1962 (63 年) |
地址: United States, Sunnyvale. CA, 320 Soquel Way - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.biocardia.com
网站: https://www.biocardia.com